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Introduction
Hepatitis C virus (HCV) is a hepatotropic virus and the 
cause of the majority of the cases of the formerly called 
“transfusion – related non-A, non-B hepatitis” with profound 
effect in the liver.[1,2] HCV infection is one of the leading public 
health challenges globally accounting for about 115 million 
infections; 11 million of whom are children younger than 
15 years of age. Similarly, about 80 million cases of the 
total global infections are viremic out of which 5 million are 
children <15 years.[3] Sub-Saharan Africa with a prevalence of 
5.3% and an estimated 32 million infected people with HCV 
have the largest global burden.
Generally, worldwide geographic prevalence and genotypic 
variations exist with reasons that are poorly understood.
Earlier studies about two and half decades ago, prior to the wide 
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Abstract
Background: Although children comprise a small fraction of the burden of hepatitis C virus 
(HCV) infections, which is a major global health challenge, a significant number of them develop 
chronic HCV infection and are at risk of its complications. Aim: The aim of the current study 
was to determine the prevalence and associated factors of HCV infection in school children 
in Enugu urban. Subjects and Methods: This was a cross‑sectional seroepidemiological study 
involving children aged 10–18 years selected using multistage systematic sampling in Enugu 
metropolis, Southeast Nigeria. The anti‑HCV was tested using a 3rd generation enzyme‑linked 
immunosorbent assay. Data were analyzed using SPSS Version 16.0 with the level of significance 
set at P < 0.05. Results: Four hundred and twenty children were selected and screened 
comprising 210 (50.0%) males and females. The seroprevalence of anti‑HCV was 4 (1.0%). 
Three (75%) out of the four positive cases for the anti‑HCV were females while one was a male 
giving a male to female ratio of 0.3–1. Traditional scarifications/tattoos were the putative risk
factors observed to be significantly associated with anti‑HCV seropositivity. Conclusion: This 
study has demonstrated an anti‑HCV seroprevalence of 1.0% among children aged 10–18 years 
in Enugu with traditional scarification as the predominant associated risk factor. Proper health 
education including school health education and promotion of behavioral change among the 
public on the practice of safe scarifications/tattoos should be encouraged in our setting.
Keywords: Anti‑hepatitis C virus, Children, Prevalence, Risk factors
Original Article





This is an open access article distributed under the terms of the Creative 
Commons Attribution‑NonCommercial‑ShareAlike 3.0 License, which allows 
others to remix, tweak, and build upon the work non‑commercially, as long as the 
author is credited and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com
How to cite this article: ***
Eke, et al.: Seroprevalence of hepatitis C virus infection in children
Annals of Medical and Health Sciences Research | May-Jun 2016 | Vol 6 | Issue 3 | 157
products for anti-HCV showed prevalence ranging from 0.4% 
to 14.5% in some series.[2-6]
HCV is transmitted primarily through percutaneous exposure.[7] 
In children, generally, perinatal (vertical) acquisition of HCV 
is the most prevalence route of transmission, with about 5% 
of infants born to mothers with HCV viremia having HCV 
through vertical transmission.[1] In addition, maternal co-viral 
infections in pregnancy including HIV, as well as high HCV, 
and RNA positive viral titers have been shown to increase the 
risk of transmission.[1]
In the developing countries, the most common route of 
transmission is unscreened-/poorly screened blood or 
plasma – derived products.[8] Other putative routes of HCV 
transmission include overuse and unsafe injection practices, 
intravenous drug use, tattooing, body piercing, and sharing of 
household nail clippers, razor blades, and toothbrushes.[9,10]
HCV is the most likely hepatotropic virus leading to chronic 
hepatitis. Generally, about 6–9% of HCV-infected children 
have been observed to achieve sustained spontaneous viral 
clearance during a 6–year follow-up irrespective of the route 
of HCV infection acquisition.[1,10] Studies have alluded to the 
fact that though majority of cases of HCV infections acquired 
in childhood appear benign, about 25% of them could develop 
liver cirrhosis and liver failure in childhood and occasionally 
hepatocellular carcinoma after 20–30 years following acute 
infections.[11,12]
HCV infection remains a major public health challenge 
particularly in developing countries where poverty and 
ignorance shape people’s perception of disease and its 
determinants in addition to the fact that there are no 
available effective vaccines owing to the high mutability 
of the viral genome. Moreover, immunoglobulins currently 
produced lack viral antibodies as anti-HCV viral screening 
is conducted on all donor blood and plasma derived 
products.[1]
Pediatric HCV infection has generally not received its 
desired attention,[13] particularly in developing countries, 
where the healthcare costs including economic impact for the 
HCV-infected children as well as their family contacts have 
been estimated at millions of the United States of American 
Dollars.[14]
Few studies have been reported on the seroepidemiology of 
HCV infections in Nigerian children,[15] where children under 
15 years of age account for about 43–45% of the 177 million 
Nigerian population.[16]
Hence, the aim of the current study is to determine the 
prevalence and risk factors of HCV infection in secondary 
school children in Enugu, Nigeria.
Subjects and Methods
Study design
This was a cross-sectional seroprevalence study conducted 
among secondary school children in Enugu metropolis 
(consisting of 3 local governments area namely: Enugu 
metropolis (consisting of 3 local government areas namely: 
Enugu East, Enugu North, and Enugu South local government 
areas) conducted between June 16, 2014 and July 31st, 2014.
Study sample size determination
The sample size for the study was calculated using the formula 
below.[17]
N = Z2pq/d2
where N = The desired sample size when the population is 
more than 10,000.
Z = The standard variation usually set at 1.96 (which 
corresponds to 95% confidence interval).
P = The population in the target population estimated to have 
a particular characteristic (Prevalence of HCV infection in 
children reported in Ibadan, South West Nigeria, by Okonko 
et al. was 0.9% which is equal to 0.09.[15]
q = 1.0 − p, i.e., 1‑0 − 0.09 = 0.91
d = degree of accuracy desired; set at 0.05.
Therefore, the minimum sample size, n = (1.96) 2 (0.09)(0.91)/
(0.05) 2
Hence, applying the formula stated above, the minimum sample 
size was 126 subjects. An attrition rate of 20% was anticipated, so 
the adjusted minimum sample size will be 151 school children.
Schooling system in study locale
Enugu is the capital city of Enugu State South Eastern Nigeria. 
Enugu State has an estimated population of about 3 million 
people,[18] while Igbo is the major ethnic group.
In Nigeria, children under 15 years of age account for about 
43–45% of the 177 million Nigerian population.[16]
Evidence from the Nigerian Demographic and Health Survey 
reveals that among children of secondary school age, 35.1% 
were attending secondary schools. Thus, the secondary school 
net attendance rate in Nigeria could be shielding the fact that 
many children are in school at a level that is not appropriate 
for their age.[19] The secondary school age in Nigeria is from 
12 to 17 years; however, in the southern parts of Nigeria, 
children much younger than 12 years could well be found 
already in secondary schools.
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Study sampling/population
A multi-staged sampling method was used to select the study 
population who were secondary school children as follows: 
A list of all the public secondary schools in the five densely 
populated areas of Enugu urban was drawn from where 
schools were selected by simple random sampling. There were 
about twenty schools spread over the five densely populated 
areas of the Enugu metropolis (Abakpa Nike, Trans Ekulu/
GRA, Emene, Achara Layout/Uwani, and New Haven/
Independence Layout). One school was selected by simple 
random sampling method from each of these areas representing 
three coeducational, one all boys and one all girls schools. Each 
school has JS classes I to SS class 3, (i.e., Classes I to VI). Each 
class has an average of about 150 students. Among the selected 
schools, the students were stratified according to their classes 
and in each class, they were further stratified based on their sex. 
The subjects were subsequently selected by the application of 
systematic sampling method where the first child was selected 
by simple random sampling, and every other fifth child was also 
selected. Fifteen children were selected from each class and 
about ninety children from each school, giving a total of 450 
children selected. Furthermore, about thirty selected children 
refused to continue with the study because of lack of parental 
consent in 23 of them while seven said they cannot withstand 
blood-letting even after series of counseling, giving a refusal 
rate of 6.7%. In all, 420 school children were recruited.
Permission for the study
Ethical approval for the study was sought from the Health 
Ethics and Research Committee of the University of Nigeria 
Teaching Hospital, Ituku-Ozalla, Enugu. Permission to conduct 
the study was obtained from the Ministry of Education Enugu 
State, Nigeria, while consent was obtained from the respective 
school principals and parents/caregivers and assents from the 
students as well.
Questionnaire
Information obtained from the semi-structured questionnaire 
designed for the study included: Biodata of each child and 
parents (age, sex, parental highest educational attainment, 
and occupation) and child’s medical history including past 
history of blood transfusion, native uvulectomy, sharing 
of toothbrush/razor blades/hair clippers or other sharps, 
traditional scarifications/tattoos, circumcision, surgery, alcohol 
use, past history of jaundice/liver disease, intravenous drug 
use, and multiple sexual partners.
Each child’s social classification was derived using the method 
proposed by Oyedeji.[20] Here, the social class of each child 
was determined based on the occupational status and highest 
educational attainment of the parents. The scores were summed 
and the mean (approximated to the nearest whole number) 
obtained. The mean score was used to assign the child to one 
of the socioeconomic Classes (1 to V). The social classes of 
the subjects were further stratified into upper (social classes 
I and II), middle (social class III), and lower (social classes 
IV and V).
Procedure for field work
Two research assistants who were house officers were trained 
for two consecutive days by the investigators, who are 
pediatricians. In the course of the training, the investigators 
and research assistants practiced on how to administer and 
fill the questionnaires and method of collection of the blood 
samples.
The questionnaire was pretested and validated 2 weeks prior 
to the commencement of the study and the content found not 
to be ambiguous.
Prior to the commencement of the study the investigators and 
research assistants visited the selected schools to familiarize 
themselves with the school authorities and students of the 
selected schools. During the familiarization visits, the students 
and teachers were given a brief talk on viral hepatitis with 
special reference to hepatitis C, its mode of transmission, 
prevention, and control. Moreover, the objective of the study 
was explained to the students. The selected students were given 
a consent form to take home to their parents for approval and 
signing and brought back the next day. On the following days, 
the respective school halls were used for the retrieval of the 
consent forms.
One semi-structured questionnaire per student was administered 
and completed by the investigators and each student.
Exclusion criteria
Subjects who had symptoms and signs suggestive of liver 
disease were excluded.
Procedure
Venous blood (5 ml) was obtained from each participant and 
tested for antibody to HCV (anti-HCV) using a third generation 
assay (ELISA) manufactured by ABON Biopharm (Hangzhou) 
Co., Ltd., P.R. China (Number: 11559996501). This test kit has 
a sensitivity of 99.0% and specificity of 98.6%.[21]
Data analysis
Data were analyzed using the statistical package for social 
sciences (SPSS) software Version 16.0 (Chicago, IL, USA) 
and presented as percentages, frequencies, whereas bivariate 
analysis was used to determine the predictive risk factors for 
HCV infection.
Results
A total of 420 children aged 10–18 years comprising 210 males 
and females were studied, giving a male to female ratio of 
1:1. The social class distribution of the study subjects is as 
shown in Table 1.
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The overall mean age was 14.26 (2.017), whereas the median 
age was 14.0.
The mean age for males was 13.97 (2.135), whereas among 
the females, it was 14.40 (1.946).
Four out of the 420 subjects tested positive to the anti-HCV 
giving an overall seroprevalence of 1% [Table 1].
75% (3/4) of the anti- HCV cases were females, whereas one 
was a male giving a male to female ratio of 0.3:1. See Table 2. 
Two were aged 10, whereas the others were between 12 and 
13 years.
The putative risk factors were more frequent in the anti-HCV 
seropositive subjects compared to the anti-HCV negative 
cases [Table 3].
When the putative risk factors were subjected to bivariate 
analysis, only traditional scarification/tattoo was statistically 
significant (P < 0.01) which are shown in Table 4.
Discussion
The seroprevalence of hepatitis C in the current study was 1.0% 
which is comparable to findings in a similar study in Nigeria 
with a reported prevalence of 0.9%.[15] It is, however, low 
when compared with other reports in some parts of sub-Sahara 
Africa.[22,23] It is pertinent to state that several recent studies 
on the seroprevalence of hepatitis C reported in Nigeria were 
with other co-morbidities including sickle cell anemia,[24-26] 
HIV,[27] and hepatitis B virus co-infections.[28]
However, the 1.0% seroprevalence of HCV reported in the 
current study could possibly be an underestimation of the actual 
prevalence as evidence from the Nigeria demographic and 
health survey reveals that among children of secondary school 
age, 35.1% were attending secondary schools,[19] implying that 
a greater percentage of the children are out of school and as 
such are not accounted for.
Although children represent a small fraction of the global burden 
of HCV infections, a substantial proportion of them have been 
reported to have chronic HCV infection and are at increased 
risk for the development of its complications including chronic 
liver cirrhosis, liver failure, and hepatocellular carcinoma at 
later age.[3] This necessitates the need to screen at risk children 
for hepatitis C viral infection.
Among the putative risk factors studied, only native 
scarifications/tattoos were significantly prevalent among 
subjects who tested positive to HCV antibodies compared 
to those who were seronegative. This implies that there 
is a significant contribution to the disease burden by 
this unwholesome practice. Similar observations have 
been made by Ejiofor et al.[26] in Enugu. The chance of 
transmitting HCV‑related infections through scarification in 
the subjects for conditions such as febrile convulsions, visible 
cardiac pulsations, enlarged abdominal organs particularly 
splenomegaly, or even for esthetic reasons may likely be 
substantial following the fact that such practices might have 
occurred several years ago and most importantly some of them 
may have co-morbidities likely to result in anemia requiring 
blood transfusion with its attendant risks if not screened for 
hepatitis C.
However, such children with known sickle cell disease, HIV 
infection were excluded from the study. HCV principal route 
Table 1: Sociodemographic characteristics of the study 
population














Table 2: Prevalence of hepatitis C according to sex
Sex Hepatitis C antibody
Negative (n=416) Positive (n=4) Total (n=420)
Male 209 (99.5) 1 (0.5) 210
Female 207 (98.6) 3 (1.4) 210
Total 416 (99.0) 4 (1.0) 420
Table 3: Distribution of risk factors of hepatitis C infection 
among the anti‑hepatitis C virus positive cases
Risk factors Hepatitis C
Negative Positive
No Yes No Yes
Previous blood transfusion 92.3 7.7 100.0 0.0
Native uvulectomy 87.0 13.0 100.0 0.0
Sharing of toothbrush 82.2 17.8 75.0 25.0
Sharing razor blades, or clippers 37.0 63.0 0.0 100.0
Traditional scarification/tattooing 87.5 12.5 50.0 50.0
Injections from quacks 41.3 41.3 50.0 50.0
Circumcision 53.8 46.2 75.0 25.0
Previous surgery 95.9 4.1 100.0 0.0
Intravenous drug use 100.0 0.0 100.0 0.0
Use of alcohol 97.6 2.4 100.0 0.0
Multiple sex partners 98.1 1.9 75.0 25.0
Past history of jaundice/liver 
disease
97.1 2.9 100.0 0.0
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of transmission is exposure to contaminated blood.[29] In the 
current study, none of the positive cases for anti-HCV reported 
past history of blood transfusion.
Further, perinatal/vertical transmission is one form of HCV 
transmission, even though it is a known less common mode of 
infection. In the current study, we could not directly ascertain 
the proportion of subjects with positive anti-HCV from 
maternal HCV positively.
The females had higher seroprevalence compared to males. 
This is in contrast to a similar Nigerian study by Okonko 
et al.[15] where more males were found to have higher positivity.
The reason for the higher female predilection may be uncertain. 
However, females are traditionally more likely to have had ear 
piercing in infancy as well as native aesthetic scarifications 
hence increasing the chances of HCV transmission in them if 
the instruments applied were unsterile.
Socioeconomic status has been observed to be associated with 
the transmission of some similar viral infections like hepatitis 
B virus infection as reported by Ugwuja and Ugwu[30] Others 
have reported varying findings showing that social class does 
not influence hepatitis B viral infection in children.[31] Though 
social class, as well as educational attainment of the children 
and parents, was not statistically associated with the prevalence 
of hepatitis C seropositivity, in the current study, it is possible 
that because the majority of the children studied were from 
upper- and middle-socioeconomic backgrounds with higher 
educational attainment they may have limited exposure to the 
possible risk factors for hepatitis C viral infection following 
their improved environmental and behavioral conditions and 
hence the low hepatitis C seroprevalence as observed in them.
The four positive subjects were aged between 10 and 13 years. 
Though we could not sight similar local studies on adolescent 
population, similar studies in Ugandan[22] had revealed higher 
positivity in younger age.
Even though other risk factors reported in this study were 
not significantly related to anti-HCV positivity such as 
injections from quacks, sharing of clippers, razor blades, 
native uvulectomy, and circumcision. It is important to note 
that such unhealthy practices could result in transmission of 
blood-related infections including hepatitis B or C and even 
HIV.[29,32-34]
Till date, pediatric HCV infections have not received the 
desired attention it deserves probably due to the fact that the 
proportion of infected children is small and that majority of 
perinatal and early childhood infections are either cleared or 
the few infected ones may not all develop the chronic stigmata 
of the disease in childhood. However, the burden of HCV 
infection should be appreciated in children
Conclusion
This study has highlighted the burden of HCV infection 
in adolescent child population in Enugu with traditional 
scarification/tattooing being the most prevalent associated 
risk factor.
Adequate health education including school health education 
and promotion of behavioral change among the general public 
to practice safe scarifications/tattooing should be encouraged 
to limit the spread of the infection.
Limitation of the study
Inability to determine the maternal HCV serostatus of the 
study subjects which could be a risk factor for its transmission.
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